Kestra Medical Technologies, Ltd. KMTS
NASDAQ
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -25.15% | -- | -- | -- | -34.72% |
| Total Depreciation and Amortization | 22.62% | -- | -- | -- | -34.23% |
| Total Amortization of Deferred Charges | 8.63% | -- | -- | -- | 137.24% |
| Total Other Non-Cash Items | 45.69% | -- | -- | -- | 560.52% |
| Change in Net Operating Assets | 102.36% | -- | -- | -- | -558.42% |
| Cash from Operations | -1.55% | -- | -- | -- | -25.21% |
| Capital Expenditure | -43.07% | -- | -- | -- | -38.58% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -61,012.79% | -- | -- | -- | 57.98% |
| Cash from Investing | -783.04% | -- | -- | -- | -38.37% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -30.18% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 22.14% | -- | -- | -- | -155.60% |
| Cash from Financing | -19.17% | -- | -- | -- | 26.89% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -231.02% | -- | -- | -- | 25.80% |